Correlation Between Sangamo Therapeutics and Century Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sangamo Therapeutics and Century Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sangamo Therapeutics and Century Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sangamo Therapeutics and Century Therapeutics, you can compare the effects of market volatilities on Sangamo Therapeutics and Century Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sangamo Therapeutics with a short position of Century Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sangamo Therapeutics and Century Therapeutics.
Diversification Opportunities for Sangamo Therapeutics and Century Therapeutics
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sangamo and Century is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Sangamo Therapeutics and Century Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Century Therapeutics and Sangamo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sangamo Therapeutics are associated (or correlated) with Century Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Century Therapeutics has no effect on the direction of Sangamo Therapeutics i.e., Sangamo Therapeutics and Century Therapeutics go up and down completely randomly.
Pair Corralation between Sangamo Therapeutics and Century Therapeutics
Given the investment horizon of 90 days Sangamo Therapeutics is expected to under-perform the Century Therapeutics. In addition to that, Sangamo Therapeutics is 2.49 times more volatile than Century Therapeutics. It trades about -0.12 of its total potential returns per unit of risk. Century Therapeutics is currently generating about -0.28 per unit of volatility. If you would invest 100.00 in Century Therapeutics on December 29, 2024 and sell it today you would lose (49.00) from holding Century Therapeutics or give up 49.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Sangamo Therapeutics vs. Century Therapeutics
Performance |
Timeline |
Sangamo Therapeutics |
Century Therapeutics |
Sangamo Therapeutics and Century Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sangamo Therapeutics and Century Therapeutics
The main advantage of trading using opposite Sangamo Therapeutics and Century Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sangamo Therapeutics position performs unexpectedly, Century Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Century Therapeutics will offset losses from the drop in Century Therapeutics' long position.Sangamo Therapeutics vs. Editas Medicine | Sangamo Therapeutics vs. Intellia Therapeutics | Sangamo Therapeutics vs. Bluebird bio | Sangamo Therapeutics vs. Alnylam Pharmaceuticals |
Century Therapeutics vs. Edgewise Therapeutics | Century Therapeutics vs. C4 Therapeutics | Century Therapeutics vs. Mineralys Therapeutics, Common | Century Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |